PARP inhibitor combination clinical trials for advanced prostate cancer - Conversation 2

touchPODCAST · May 5, 2022 · 12m

touchMDT for touchONCOLOGY

Listen to a urologist and a medical oncologist discuss key clinical trials investigating PARP inhibitor combinations for the treatment of advanced prostate cancer.

The multidisciplinary team

Urologist: Professor Axel Merseburger, Germany

Medical Oncologist: Dr Wassim Abida, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Pfizer. This activity is jointly provided by USF Health and touchIME.

For further information visit our website…